Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis

Metformin was proposed to be a candidate for host-directed therapy for COVID-19. However, its efficacy remains to be validated. In this study, we compared the outcome of metformin users and nonusers in hospitalized COVID-19 patients with diabetes. Hospitalized diabetic patients with confirmed COVID-...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of tropical medicine and hygiene Jg. 103; H. 1; S. 69
Hauptverfasser:	Luo, Pan, Qiu, Lin, Liu, Yi, Liu, Xiu-Lan, Zheng, Jian-Ling, Xue, Hui-Ying, Liu, Wen-Hua, Liu, Dong, Li, Juan
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.07.2020
Schlagworte:	Aged Betacoronavirus China Coronavirus Infections - complications Coronavirus Infections - mortality Coronavirus Infections - therapy COVID-19 Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Female Hospital Mortality Humans Hypoglycemic Agents - therapeutic use Length of Stay Male Metformin - therapeutic use Middle Aged Pandemics Pneumonia, Viral - complications Pneumonia, Viral - mortality Pneumonia, Viral - therapy Retrospective Studies SARS-CoV-2 China
ISSN:	1476-1645, 1476-1645
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!